Initiative Capital

Europe, Alsace, France, Sausheim

Description

Initiative Capital is a Sausheim-based venture capital firm that supports entrepreneurs who are unable to find financing from banks.

Investor Profile

Initiative Capital has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

Concentrates on Series Unknown, Series C, Series B rounds (top funding stages).
Majority of deals are located in Switzerland.
Strong thematic focus on Health Care, Biotechnology, Therapeutics.

Stage Focus

Series Unknown (25%)
Series C (25%)
Series B (25%)
Series A (25%)

Country Focus

Switzerland (100%)

Industry Focus

Health Care
Biotechnology
Therapeutics
Education
Internet
Sports
Video
Medical Device
Medical
Pharmaceutical

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Initiative Capital frequently co-invest with?

Gimv

Europe, Antwerpen, Belgium, Antwerpen

Co-Investments: 1

Sectoral Asset Management

Sectoral Asset Management

North America, Quebec, Canada, Montréal

Co-Investments: 1

VI Partners

Europe, Schwyz, Switzerland, Altendorf

Co-Investments: 2

Venture Partners

Venture Partners

North America, Mexico, Mexico, Chapultepec

Co-Investments: 1

NGN Capital

North America, New York, United States, New York

Co-Investments: 1

Andera Partners

Andera Partners

Europe, Ile-de-France, France, Paris

Co-Investments: 1

Neomed Management

Neomed Management

Europe, Oslo, Norway, Oslo

Co-Investments: 1

Nomura International

Nomura International

Europe, England, United Kingdom, London

Co-Investments: 1

Affentranger Associates

Europe, Zurich, Switzerland, Zürich

Co-Investments: 1

Intel Capital

North America, California, United States, Santa Clara

Co-Investments: 1

What are some of recent deals done by Initiative Capital?

Geneva, Geneve, Switzerland

Endosense is a medical tech company focused on improving the reproducibility of catheter ablation for the treatment of cardiac arrhythmias.

BiotechnologyHealth CareMedical DeviceTherapeutics

Series CNov 27, 2012

Amount Raised: $40,300,000

Epalinges, Vaud, Switzerland

Xigen, a biopharmaceutical company, develops therapeutics to inhibit intracellular protein interactions.

BiopharmaBiotechnologyTherapeutics

Series ASep 6, 2005

Amount Raised: $21,000,000

Addex Therapeutics

Plan-les-ouates, Geneve, Switzerland

Addex Therapeutics is a biopharmaceutical company that discovers and develops allosteric modulators for human health.

BiotechnologyHealth CareMedicalPharmaceutical

Series BMay 17, 2004

Amount Raised: $39,644,926

Fribourg, Fribourg, Switzerland

Dartfish develops online and offline video solutions for coaches, athletes, pros, students, teachers, healthcare, and sports organizations.

EducationHealth CareInternetSportsVideo

Series UnknownJul 12, 2002

Amount Raised: $2,969,888